Congress Platform

ESMO events

ESMO Sarcoma&GIST Virtual Symposium 2022

topics

Sarcomas Cancer in Special Situations / Population Gastrointestinal cancers Cancer Immunology and Immunotherapy Bioethics, legal and economic issues

Date

Reset

Search results (9)

14 Jan 2022

ESMO Sarcoma & GIST Symposium 2022

Watch video

Congress_audience_01

Sarcomas

31 Jan 2022

Is there a future for immunotherapy in sarcoma?

Read more

Molecular management of metastatic GIST – challenges and opportunities

Gastrointestinal cancers

31 Jan 2022

Molecular management of metastatic GIST – challenges and opportunities

Read more

Single-agent doxorubicin – is it still the standard first-line therapy for all soft tissue sarcoma subtypes?

Sarcomas

31 Jan 2022

Single-agent doxorubicin – is it still the standard first-line therapy for all soft tissue sarcoma subtypes?

Read more

What is on the horizon for the management of osteosarcoma?

Sarcomas

31 Jan 2022

What is on the horizon for the management of osteosarcoma?

Read more

Poster area_01

Sarcomas

31 Jan 2022

Incorporating proteomics into sarcoma research: where do we stand?

Read more

Public 4

Bioethics, legal and economic issues

31 Jan 2022

What level of evidence do we need for drug approval in rare cancers?

Read more

Gronchi Alessandro

Sarcomas

31 Jan 2022

Do the pros of neoadjuvant chemotherapy in sarcoma outweigh the cons?

Neoadjuvant chemotherapy is on course to become standard treatment for selected high-risk soft tissue sarcomas but effects in low-risk disease are unclear

By Alessandro Gronchi

Read more

Dei Tos Paolo

Sarcomas

31 Jan 2022

Progress is being made in treating sarcomas in adolescents and young people

Despite age-specific difficulties, increased understanding of sarcoma biology is leading the way to the development of new treatment strategies

By Paolo Dei Tos

Read more

Daily Reporter

Twitter
Facebook
Youtube
RSS
LinkedIn
Instagram

30169140e251db563e46719de7ec91e4

ESMO is a Swiss-registered not-for-profit organisation. All funding for this site is provided directly by ESMO. Via Ginevra 4, 6900 Lugano – CH

© Copyright 2023 European Society for Medical Oncology
All rights reserved worldwide.

Home
Editorial Board
All Editions

Privacy Policy
ESMO Website

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

Necessary cookies
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.